Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208533 · ClinicalTrials.gov registry record · Phase 2
Aripiprazole in Children With Autism: A Pilot Study
A Phase 2 study of Autism, sponsored by Drexel University College of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT00208533: Completed Phase 2 study of Autism, sponsored by Drexel University College of Medicine.
NCT00208533 is a Phase 2 study of Autism that has completed, run by Drexel University College of Medicine. The registered enrollment target is 11 participants, below the 183-participant average among 104 other Autism trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00208533, a Phase 2 study of Autism, has completed, sponsored by Drexel University College of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a 6-week open pilot study of aripiprazole for the treatment of adolescents, aged 12 to 18 years, diagnosed with autism. Children who qualify for the study will be treated with aripiprazole for 6 weeks. Treatment is provided at no cost.
Conditions Studied
Interventions
- DRUG Aripiprazole
Study Locations (1)
Pennsylvania
- Drexel University College of Medicine at Friends Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2004-02 |
| Est. Completion | 2011-11-16 |
| Phase | Phase 2 |
What the finished NCT00208533 record still lists
NCT00208533 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 183-participant average among 104 other Autism trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Autism appearing as the primary indexed condition, and to 1 intervention - of which Aripiprazole is the first listed.
NCT00208533 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00208533 about?
NCT00208533 is a clinical study titled "Aripiprazole in Children With Autism: A Pilot Study". This is a 6-week open pilot study of aripiprazole for the treatment of adolescents, aged 12 to 18 years, diagnosed with autism. Children who qualify for the study will be treated with aripiprazole for 6 weeks. Treatment is provided at no cost.
What is the current status of trial NCT00208533?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 11 participants. The study started on 2004-02. Estimated completion is 2011-11-16.
What conditions does trial NCT00208533 study?
This clinical trial studies the following conditions: Autism.
What interventions are being tested in trial NCT00208533?
The interventions under investigation include: Aripiprazole (DRUG).
Who is sponsoring clinical trial NCT00208533?
This trial is sponsored by Drexel University College of Medicine, which has 25 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00208533 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autism
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00208533's enrollment target sits among peer trials
11 100th of 104 higher than 4 of 104 other Autism trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autism trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Optimizing Outcomes for Young Autistic Children
RECRUITING · Phase 2
-
The Impact of a Virtual Magic Trick Training Program
RECRUITING · Phase 2
-
Trial of Zolpidem for Sleep in Children With Autism
RECRUITING · Phase 2
-
A Study of Esomeprazole in Children With Autism
RECRUITING · Phase 2
-
Trial of Diphenhydramine for Sleep in Children With Autism
RECRUITING · Phase 2
-
Trial of Suvorexant for Sleep in Children With Autism
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia